Effect of baseline CD4 cell count on virological and immunological outcomes of patients initiated on antiretroviral therapy: Results from a large-scale HIV programme in Rwanda
Citations
87
8.7 per year
Published
2015

Effect of baseline CD4 cell count on virological and immunological outcomes of patients initiated on antiretroviral therapy: Results from a large-scale HIV programme in Rwanda

PLoS One2015
Authors

S Nsanzimana, E Remera, S Kanters, K Chan, E Karita, JI Forrest, N Ford, A Binagwaho, EJ Mills

Antiretroviral Therapy

Abstract

Background: The optimal CD4 cell count threshold for initiating antiretroviral therapy has been a subject of ongoing debate. We analyzed the effect of baseline CD4 cell count on treatment outcomes in Rwanda's national HIV program.

Related Publications

Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis
Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis
The Lancet HIV2017
The Lancet
HIV/AIDS
Read More
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis
The Lancet HIV2016
The Lancet
HIV/AIDS
Read More
Durability of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in high-burden HIV countries: a multinational cohort study
Durability of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in high-burden HIV countries: a multinational cohort study
The Lancet HIV2021
The Lancet
HIV/AIDS
Read More